# Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny

> **NCT02634060** · NA · COMPLETED · sponsor: **Universitaire Ziekenhuizen KU Leuven** · enrollment: 140 (actual)

## Conditions studied

- Crohn Disease
- Colitis, Ulcerative

## Interventions

- **DEVICE:** Home Based Fecal Calprotectin

## Key facts

- **NCT ID:** NCT02634060
- **Lead sponsor:** Universitaire Ziekenhuizen KU Leuven
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03-31
- **Primary completion:** 2018-06-01
- **Final completion:** 2022-09-05
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2024-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02634060

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02634060, "Home basEd faecaL calProtectin Measurements Predicting Adalimumab Induction Destiny". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02634060. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*